Literature DB >> 24090707

Creatine and guanidinoacetate reference values in a French population.

Marie Joncquel-Chevalier Curt1, David Cheillan, Gilbert Briand, Gajja S Salomons, Karine Mention-Mulliez, Dries Dobbelaere, Jean-Marie Cuisset, Laurence Lion-François, Vincent Des Portes, Allel Chabli, Vassili Valayannopoulos, Jean-François Benoist, Jean-Marc Pinard, Gilles Simard, Olivier Douay, Kumaran Deiva, Marc Tardieu, Alexandra Afenjar, Delphine Héron, François Rivier, Brigitte Chabrol, Fabienne Prieur, François Cartault, Gaëlle Pitelet, Alice Goldenberg, Soumeya Bekri, Marion Gerard, Richard Delorme, Nicole Porchet, Christine Vianey-Saban, Joseph Vamecq.   

Abstract

Creatine and guanidinoacetate are biomarkers of creatine metabolism. Their assays in body fluids may be used for detecting patients with primary creatine deficiency disorders (PCDD), a class of inherited diseases. Their laboratory values in blood and urine may vary with age, requiring that reference normal values are given within the age range. Despite the long known role of creatine for muscle physiology, muscle signs are not necessarily the major complaint expressed by PCDD patients. These disorders drastically affect brain function inducing, in patients, intellectual disability, autistic behavior and other neurological signs (delays in speech and language, epilepsy, ataxia, dystonia and choreoathetosis), being a common feature the drop in brain creatine content. For this reason, screening of PCDD patients has been repeatedly carried out in populations with neurological signs. This report is aimed at providing reference laboratory values and related age ranges found for a large scale population of patients with neurological signs (more than 6 thousand patients) previously serving as a background population for screening French patients with PCDD. These reference laboratory values and age ranges compare rather favorably with literature values for healthy populations. Some differences are also observed, and female participants are discriminated from male participants as regards to urine but not blood values including creatine on creatinine ratio and guanidinoacetate on creatinine ratio values. Such gender differences were previously observed in healthy populations; they might be explained by literature differential effects of testosterone and estrogen in adolescents and adults, and by estrogen effects in prepubertal age on SLC6A8 function. Finally, though they were acquired on a population with neurological signs, the present data might reasonably serve as reference laboratory values in any future medical study exploring abnormalities of creatine metabolism and transport.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Creatine; Creatinine; Guanidinoacetate; Laboratory values; Plasma; Urine

Mesh:

Substances:

Year:  2013        PMID: 24090707     DOI: 10.1016/j.ymgme.2013.09.005

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  8 in total

Review 1.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

2.  Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency.

Authors:  Martina Huemer; Daniel R Carvalho; Jaime M Brum; Özlem Ünal; Turgay Coskun; James D Weisfeld-Adams; Nina L Schrager; Sabine Scholl-Bürgi; Andrea Schlune; Markus G Donner; Martin Hersberger; Claudio Gemperle; Brunhilde Riesner; Hanno Ulmer; Johannes Häberle; Daniela Karall
Journal:  J Inherit Metab Dis       Date:  2016-04-01       Impact factor: 4.982

3.  Untargeted LC/MS-Based Metabolic Phenotyping of Hypopituitarism in Young Males.

Authors:  Yuwen Zhang; Shouyue Sun; Ming Wang; Wenjuan Yu; Peizhan Chen; Fei Yuan; Xuqian Fang
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

4.  Serum GAA as a Possible Biomarker of Exhaustive Exercise?

Authors:  Sergej M Ostojic; Valdemar Stajer; Laszlo Ratgeber; Jozsef Betlehem; Pongras Acs; Andras Olah
Journal:  Front Physiol       Date:  2019-12-12       Impact factor: 4.566

Review 5.  Safety of Dietary Guanidinoacetic Acid: A Villain of a Good Guy?

Authors:  Sergej M Ostojic
Journal:  Nutrients       Date:  2021-12-24       Impact factor: 5.717

6.  Effects of guanidinoacetic acid supplementation on nitrogen retention and methionine flux in cattle.

Authors:  Mehrnaz Ardalan; Matt D Miesner; Christopher D Reinhardt; Daniel U Thomson; Cheryl K Armendariz; J Scott Smith; Evan C Titgemeyer
Journal:  J Anim Sci       Date:  2021-06-01       Impact factor: 3.338

7.  Guanidinoacetic Acid and Creatine are Associated with Cardiometabolic Risk Factors in Healthy Men and Women: A Cross-Sectional Study.

Authors:  Sergej M Ostojic; Milan Vranes; Davor Loncar; Natasa Zenic; Damir Sekulic
Journal:  Nutrients       Date:  2018-01-13       Impact factor: 5.717

Review 8.  Guanidinoacetic acid deficiency: a new entity in clinical medicine?

Authors:  Sergej M Ostojic; Laszlo Ratgeber; Andras Olah; Jozsef Betlehem; Pongras Acs
Journal:  Int J Med Sci       Date:  2020-09-12       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.